Your session is about to expire
← Back to Search
Virtual Rehab for Stroke ((VAST-rehab2) Trial)
N/A
Waitlist Available
Led By Sean Savitz, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosed with hemorrhagic or ischemic stroke
Diagnosed with hemorrhagic or ischemic stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
(VAST-rehab2) Trial Summary
This trial evaluates the effectiveness of a virtual rehab program in stroke patients, to help them reach their goals and reduce readmissions.
Who is the study for?
This trial is for individuals who've had a stroke confirmed by CT or MRI, with mild to moderate motor or cognitive impairments. They should be able to follow verbal commands and use the internet, have been recommended for self-guided or in-person rehab, and not have severe other illnesses that could limit survival.Check my eligibility
What is being tested?
The study is testing a virtual rehabilitation program (VAST 2) for stroke patients. It aims to see if this home-based telerehabilitation is feasible and effective in improving patient's abilities, reducing hospital readmissions, and overcoming barriers related to social determinants of health.See study design
What are the potential side effects?
Since this trial involves non-invasive telerehabilitation exercises guided virtually, side effects are minimal but may include discomfort from physical activity or frustration with technology use.
(VAST-rehab2) Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with a stroke.
Select...
I have been diagnosed with a stroke.
Select...
I was mostly independent before my stroke.
Select...
My doctor or therapist has recommended rehab activities for me.
Select...
I can understand and follow verbal instructions.
Select...
I have some difficulties with movement or thinking clearly.
(VAST-rehab2) Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of participants that completed all scheduled visits.
The experience of the participant measured by the participant experience surveys
Secondary outcome measures
Change in cognitive impairment as assessed by the Montreal Cognitive Assessment (MoCA)
Change in depression as assessed by the Patient Health Questionnaire (PHQ8)
Change in disability as assessed by the Modified Rankin Scale (mRS)
+20 more(VAST-rehab2) Trial Design
1Treatment groups
Experimental Treatment
Group I: Telerehabilitation (VAST 2)Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
902 Previous Clinical Trials
321,106 Total Patients Enrolled
42 Trials studying Stroke
7,392 Patients Enrolled for Stroke
Lone Star Stroke ConsortiumUNKNOWN
Sean Savitz, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
5 Previous Clinical Trials
315 Total Patients Enrolled
5 Trials studying Stroke
315 Patients Enrolled for Stroke
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with a stroke.I was mostly independent before my stroke.I can understand and follow verbal instructions.My doctor or therapist has recommended rehab activities for me.I have some difficulties with movement or thinking clearly.A doctor must use a CT scan or MRI to confirm that you had a stroke.I have been diagnosed with a stroke.I have some difficulties with movement or thinking.I do not have a severe illness that could shorten my life to under 6 months.I have a condition like Parkinson's or severe arthritis that significantly limits my daily activities.
Research Study Groups:
This trial has the following groups:- Group 1: Telerehabilitation (VAST 2)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Stroke Patient Testimony for trial: Trial Name: NCT05737524 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any slots available for individuals to take part in this experiment?
"The data hosted on clinicaltrials.gov reveals that this medical study, posted initially on March 1st 2023 and recently updated February 20th 2023, is no longer recruiting candidates. However, there are still 1045 other trials searching for participants at the present moment."
Answered by AI
Who else is applying?
What state do they live in?
Texas
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
Hoping this trail can help me understand how I had a stroke.
PatientReceived 1 prior treatment
Share this study with friends
Copy Link
Messenger